← DrugApprovals
HomeDrug Approvals

LAMISIL (TERBINAFINE) — FDA Approval NDA020846 (KARO HLTHCARE)

LAMISIL (TERBINAFINE) — FDA Approval NDA020846 (KARO HLTHCARE) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: LAMISIL; Active ingredients: TERBINAFINE; Application number: NDA020846.

Brand nameLAMISIL
Active ingredientsTERBINAFINE
Application numberNDA020846
SponsorKARO HLTHCARE
Dosage formGEL
RouteTOPICAL
Marketing statusDiscontinued
Products in application1
First approval date19980429
SourceopenFDA Drugs@FDA

🔍 Search all drug approvals →